Envista Holdings Corporation Common stock, $0.01 par value per share

Envista's 58× P/E is strikingly elevated for a dental equipment supplier, suggesting either exceptional growth expectations or significant overvaluation relative to cyclical peers. The RSI of 36.8 indicates oversold conditions despite the lofty multiple, creating an asymmetric risk picture—further downside could expose weakness, yet the depressed momentum leaves room for mean-reversion rallies. With 7.58% of float shorted and the stock trading well below 52-week highs, there's a potential squeeze catalyst if sentiment shifts. The $3.9B market cap commands premium pricing for what's fundamentally a discretionary-spending business vulnerable to economic slowdowns, making the current valuation a high-wire act dependent on execution.